New DCF Analysis Suggests Sherwin-Williams Significantly Overvalued at $350, Intrinsic Value $224

What happened

A new GuruFocus DCF analysis published on August 18, 2026, assigns Sherwin-Williams an intrinsic value of $224 per share, against a current market price near $350. This valuation stands far below the company's own scenarios: the DeepValue master report had modeled a base case implied value of $335, bear case $290, and bull case $365, with an attractive entry at $300 and trim above $360. The DCF's low value likely reflects more conservative assumptions on growth, margins, or discount rate, possibly factoring in the company's elevated leverage, tariff-driven raw material inflation, and continued soft housing-linked demand that management itself has acknowledged. The current price of $349.97 implies investors are pricing a quick recovery in volumes and sustained pricing power that may not materialize according to this DCF. This new analysis adds weight to the WAIT rating from the master report, suggesting the stock carries substantial valuation risk if the market re-rates toward fundamentals.

Implication

The new DCF value of $224 raises the risk of a sharp de-rating if market sentiment shifts, especially since the stock has rallied from $325 to $350 despite no major improvement in fundamentals. The DeepValue report's bear case of $290 now appears optimistic relative to this independent valuation, suggesting that tariff-driven cost pressures and weak housing demand could compress earnings more than previously modeled. In the near term, the stock may remain elevated due to its quality compounder narrative, but investors should be cautious: if upcoming quarterly results fail to show gross margin expansion or volume recovery, the gap between price and intrinsic value could close rapidly. For existing holders, using strength above $360 to trim would be prudent, while new buyers should wait for a pullback toward the $224-$300 range that offers a margin of safety. Over the long term, the company's strong distribution moat and cash generation remain intact, but at a premium valuation, the risk-reward is skewed to the downside until fundamentals catch up with price.

Thesis delta

The new DCF analysis materially lowers the estimated fair value from the $335 base case implied by the master report to $224, indicating that the market may be overestimating Sherwin-Williams' growth and margin resilience. This shifts the thesis from simply 'wait for proof' to a more defensive stance: the stock is now not just expensive relative to near-term earnings but potentially overvalued by over 35% even under conservative assumptions. The burden of proof has increased, and the investment case now hinges on either a significant upward revision in intrinsic value drivers or a substantial price correction.